title: [Locoregional anesthesia and drugs that affect hemostasis. Suggestions of the expert meeting in the ESRA Congress in Barcelona].
abstract: Growing interest in the effect of hemostasis-altering medications on regional anesthetic techniques was analyzed recently in a review article suggesting certain safety measures, by Llau and colleages in Revista Española de Anestesiología y Reanimación. Since that review, however, it has become necessary to extend the discussion of clinical issues, based on information presented at the Eighth Local Meeting of the European Society for Regional Anesthesia (ESRA) of May 2002. There, participants debated the most controversial aspects, with attention to practical questions such as temporal safety margins and approaches to take given certain platelet antiaggregants, fibrinolytics or drug combinations. This paper faithfully presents the suggestions made by participants at the meeting. As most anesthesiologists expressed the need to set guidelines for fibrinolytics, the main issues related to those drugs in regional anesthesia are reviewed.
authors.affiliation: Servicio de Anestesiología, Reanimación y Terapéutica del Dolor Hospital Clínico Universitario de Valencia Avda. Blasco Ibáñez, 17, 46010 Valencia. juanvllau@terra.es
authors.forename: Juan V
authors.initials: JV
authors.lastname: Llau Pitarch
authors.forename: José
authors.initials: J
authors.lastname: De Andrés Ibáñez
authors.forename: Carmen
authors.initials: C
authors.lastname: Gomar Sancho
authors.forename: Aurelio
authors.initials: A
authors.lastname: Gómez Luque
authors.forename: Francisco
authors.initials: F
authors.lastname: Hidalgo Martínez
authors.forename: Luis M
authors.initials: LM
authors.lastname: Torres Morera
mesh_terms: D000772:Anesthesia, Local; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006487:Hemostasis / Q000187:drug effects*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors